Autopsy report · NCT03823703

Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Miricorilant in Participants With Presumed Nonalcoholic Steatohepatitis (NASH)

“Suspended by sponsor, pending investigation of abnormal laboratory values in patients with NASH”

The sponsor’s own words in the registry.

Life of this trial

• Registered 1 year 10 months before it started.
• Ran for about 5 months before it stopped.
• 12 participants enrolled.
• Results were posted on the registry 1 year 5 months after it ended.

Vital statistics

Status

Terminated

Phase

Phase 2

Sponsor

Corcept Therapeutics

Sponsor type

Industry

Conditions

Nonalcoholic Steatohepatitis (NASH)

Interventions

Miricorilant; Placebo

Participants

12

Sites

15

Countries

United States

Trials that died the same way

• Autologous Stem Cells in Pediatric Patients With Dilated Cardiomyopathy
  “Suspended because the lack of patients among the time this clinical trial was running.” (56% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.